The New RSV Drug Keeps Babies Out of the Hospital
Beyfortus is effective at protecting infants from severe RSV, but it’s in short supply.
Stay updated with breaking news from Rick Malley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beyfortus is effective at protecting infants from severe RSV, but it’s in short supply.
Supplies of monoclonal antibodies that protect infants will remain tight through this season.
Few people are rolling up their sleeves for the new COVID, flu and RSV vaccines, even as peak respiratory virus season is looming, according to state and federal data.
Human metapneumovirus, or HMPV, is an illness that affects the upper respiratory system, causing similar COVID-19 symptoms, such as cough, sore throat, and fever. While it can affect people of all ages, the risk is higher for children, older adults, and those with compromised immune systems
The United States Centers for Disease Control and Prevention (CDC) warned of a surge in cases of Human metapneumovirus (hMPV), which is considered a generally unknown virus.